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Summary In the neonatal period, the surgical mortality of palliation is extremely high for
asplenia syndrome complicated by single ventricle combined with total anomalous pulmonary
venous connection (TAPVC). Recently, stent implantation for the pulmonary venous drainage
route soon after birth has been used instead of surgery to prevent pulmonary venous occlusion
and to maintain stable hemodynamics in the neonatal period or in early infancy. Here, we
successfully implanted stents in the ductus venosus (DV) in 2 neonates with asplenia syndrome
complicated by infracardiac type TAPVC. The ﬁrst patient was a 3-day-old male neonate withCatheter intervention severe cyanosis. Immediately after TAPVC was diagnosed, we implanted a stent in the DV.
The second patient was a 0-day-old female neonate. She was diagnosed as TAPVC by fetal
echocardiogram. After the scheduled delivery, a stent was successfully implanted. We believe
that stent implantation in the DV in the neonatal period is effective and less invasive than
surgery in patients with infracar
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ntroductionhe fate of infants with functional single ventricle such
s in asplenia syndrome complicated by total anomalous
ulmonary venous connection (TAPVC) is catastrophic com-
ared to that of infants without TAPVC [1]. The current
Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 Portal venogram (patient 1). Portal venogram
through the umbilical vein shows the course of the ductus veno-
sus (DV). The DV had already started to close. UV, umbilical
vein.130
urgical mortality of isolated TAPVC is less than 10% and
ost patients successfully survive, while the outcome is
nfavorable for patients with associated complex cardiac
alformations [2]. It has been reported that an early age
t initial operation, the need of palliative surgery with
ardiopulmonary bypass, and an obstructed TAPVC are risk
actors for mortality in these patients [1,2]. Even though
he surgical outcome has recently been improving in these
atients [1,3,4], mortality is still high among patients
ith heterotaxy treated in the modern surgical era [5],
nd this situation continues to remain extremely challeng-
ng [6]. Patients with obstructed TAPVC, especially of the
nfracardiac type, usually present with critical illness. This
equires alternative and aggressive management strategies,
or instance, a stent implantation to maintain the pulmonary
enous drainage and stable hemodynamics in the neonatal
eriod or early infancy [2,7].
We successfully implanted stents in the ductus veno-
us (DV) in 2 neonates with asplenia syndrome complicated
y infracardiac type TAPVC [8]. Our novel strategy, stent
mplantation in the DV, may be a better alternative to early
urgery for the treatment of infracardiac type TAPVC in
splenia syndrome.
ase reports
atient 1
3-day-old male neonate, who was born at 39 weeks of
estation with a birth weight of 3000 g, was referred to our
ospital with complaints of severe cyanosis. At admission,
he SpO2 was 55%. Physical examination and echocardio-
ram revealed that the patient had asplenia syndrome,
itus ambiguous, D-loop, D-transposition (A, D, D), single
ight ventricle, common atrium, pulmonary atresia, com-
on atrioventricular canal defect, patent ductus arteriosus,
nfracardiac type TAPVC, right aortic arch, and bilateral
uperior vena cava. His cyanosis gradually improved by
he administration of lipo-prostaglandin E1; however, the
ulmonary congestion progressed with closing DV (Fig. 1).
t 3 days of admission, cardiac catheterization and stent
mplantation in the DV was performed as follows. First, the
mbilical vein was secured using a 6F sheath. A 6F multipur-
ose catheter was inserted into the portal vein through the
mbilical vein. Portal venogram was used to ﬁnd the exact
oute of the DV. Through the DV, a guide wire (0.014 in.)
as carefully inserted into the common atrium. Since the
V had already started to close, it was difﬁcult to pass
he guide wire through the DV. Keeping the guide wire
n the common atrium, a stent mounted on the balloon
atheter was introduced over the guide wire and the stent
as located in the DV. We successfully implanted the stents
GFX Micro-stents, 1 piece of diameter 3mm and length
4mm, and 2 pieces of diameter 3mm and length 18mm) in
he DV from the atrium to the portal vein (Fig. 2). We con-
rmed that the ﬂow through the DV was adequate by both
ngiogram and echocardiogram. Biphasic ﬂow pattern was
etected in the stent by a Doppler echocardiogram. Chest
-ray revealed that pulmonary congestion had disappeared.
fter the procedure, heparin (100U/(kg day), intravenously)
nd aspirin (5mg/(kg day), orally) were administered. Pul-
Figure 2 Stent implantation (patient 1). We successfully
implanted the stents (GFX Micro-stents, 1 piece of diameter
3mm and length 24mm, and 2 pieces of diameter 3mm and
length 18mm) retrogradely in the ductus venosus from the
atrium to the portal vein.
Stenting of the ductus venosus
Figure 3 The late phase of the balloon-occlusion descending
aortogram showing the pulmonary venous return root (patient
2). The projected contrast media enters bilateral lung via pul-
monary arteries through the patent ductus arteriosus and then
ﬂows back into the pulmonary veins, the VV and ﬁnally the DV
where the stent (Palmaz stent 2408 of diameter 8mm and length
T
p
D
T
D
t
a
t
T
c
i
r
t
m
p
t
s
i
i
C
a
p
i
p
q
i
a
r
w
s
b
d
i
t
a
s
i
s
b
w
i
R
[
[24mm) was implanted. The sufﬁcient pulmonary venous return
ﬂows inside the stent. VV, vertical vein; DV, ductus venosus; PV,
portal vein.
monary venous return was not obstructive and the clinical
course after the stent implantation was good. At the age
of 8 days, Blalock-Taussig shunt was created successfully
and lipo-prostaglandin E1 could be discontinued. One month
after the stent implantation, SpO2 gradually decreased
owing to restenosis of the DV. We performed redilation of the
stent with a 5mm balloon catheter. As the umbilical vein had
already closed at that time, we retrogradely approached the
DV from the right jugular vein through the common atrium.
The SpO2 improved from 65% to 82%. At the age of 4 months,
TAPVC repair was performed.
Patient 2
A female neonate was born at 38 weeks of gestation with a
birth weight of 2580 g by scheduled Cesarean section. The
patient was diagnosed with asplenia syndrome (A, D, D),
single right ventricle, common atrium, pulmonary atresia,
common atrioventricular canal, patent ductus arteriosus,
infracardiac type TAPVC, and bilateral superior vena cava
according to the fetal echocardiogram. We successfully
performed a stent implantation in the DV after birth. As
described for Patient 1, we implanted the stents (Palmaz
stent 2408 of diameter 8mm and length 24mm) in the DV.
A stent with a larger diameter was selected since the ﬁrst
case demonstrated the importance of using a larger stent
to maintain an optimal ﬂow for a long period. A sufﬁcient
ﬂow through the DV was maintained and redilation of the
stent was not required (Fig. 3). At the age of 3 months,
[e131
APVC repair, right ventricle-pulmonary artery shunt, and
ulmonary artery angioplasty were performed.
iscussion
his is the ﬁrst report of successful stent implantation in the
V in 2 newborns with asplenia syndrome with infracardiac
ype TAPVC in order to prevent pulmonary venous occlusion
nd maintain an adequate ﬂow from the pulmonary vein into
he atrium.
In asplenia syndrome complicated by infracardiac type
APVC, pulmonary congestion progresses rapidly after the
losure of the DV. The mortality rate of the palliative surgery
s extremely high for TAPVC in the neonatal period. As a
esult, the prognosis of asplenia syndrome with infracardiac
ype TAPVC remains poor [1,3,4]. Therefore, an alternative
ethod is required in order to treat TAPVC in the neonatal
eriod. Catheter intervention is one of the most impor-
ant treatments in complex heart diseases [7,9]. Our novel
trategy, stent implantation in the DV, is effective and less
nvasive than early surgery.
Since the DV closes quickly after birth, stent implantation
n the DV becomes very difﬁcult as the infant grows older.
onsequently, this condition has to be diagnosed immedi-
tely and our procedure should be performed as soon as
ossible before the closure of the DV. For better results,
ntrauterine diagnosis by fetal echocardiogram should be
erformed, followed by pre-mediated delivery and subse-
uent stent implantation.
In the ﬁrst patient, the restenosis of the DV caused by
ntimal proliferation occurred 1 month after the procedure,
nd redilation of the stent up to 5mm in size was eventually
equired. In our experience, the appropriate size of the stent
as at least 8mm for these neonates; the best size of the
tent for longer patency should be investigated in the future.
Most importantly, stent implantation in the DV soon after
irth could delay the requirement for surgery with car-
iopulmonary bypass in the neonatal period. Myocardial
schemia following cardiopulmonary bypass may cause dele-
erious cardiac dysfunction in neonates after surgery. These
dverse effects may lead to high mortality after cardiac
urgery in these patients. Our strategy is less invasive and is
ntended to improve the prognosis of patients with asplenia
yndrome with infracardiac type TAPVC.
In conclusion, stent implantation in the DV soon after
irth is an effective and less invasive therapy for neonates
ith complex congenital heart disease, particularly with
nfracardiac type TAPVC.
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